Arcutis Biotherapeutics (ARQT) Goodwill & Intangibles (2022 - 2026)

Arcutis Biotherapeutics' Goodwill & Intangibles history runs 5 years deep, the most recent figure standing at $14.2 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 13.64% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $14.2 million (down 13.64% YoY), while the FY2025 annual figure was $14.8 million, up 56.26% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $14.2 million, down from $14.8 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $16.5 million in Q1 2025, with the low at $6.1 million in Q2 2024.
• The 5-year median for Goodwill & Intangibles is $7.4 million (2022), against an average of $10.0 million.
• The sharpest annual moves came in 2025 and 2026: Goodwill & Intangibles surged 164.0% in 2025, then dropped 13.64% in 2026.
• Arcutis Biotherapeutics' Goodwill & Intangibles stood at $7.2 million in 2022, then declined by 10.43% to $6.4 million in 2023, then jumped by 47.24% to $9.5 million in 2024, then soared by 56.26% to $14.8 million in 2025, then dropped by 3.79% to $14.2 million in 2026.
• Business Quant data shows ARQT's Goodwill & Intangibles at $14.2 million in Q1 2026, $14.8 million in Q4 2025, and $15.4 million in Q3 2025.